首页|《中国慢性胃炎诊治指南(2022年,上海)》解读:萎缩性胃炎癌变风险评估和监测

《中国慢性胃炎诊治指南(2022年,上海)》解读:萎缩性胃炎癌变风险评估和监测

Interpretation on Guidelines for Diagnosis and Treatment of Chronic Gastritis in China(2022,Shanghai):Risk Assessment and Monitoring of Canceration in Atrophic Gastritis

扫码查看
2022年,中华医学会消化病学分会对《中国慢性胃炎共识意见(2017年,上海)》进行更新,制定了《中国慢性胃炎诊治指南(2022年,上海)》(以下简称2022版胃炎指南).2022版胃炎指南针对慢性胃炎的九方面临床问题,提出53项推荐意见.现对2022版胃炎指南中有关萎缩性胃炎的癌变风险分层、内镜监测策略等内容作一解读.
In 2022,Chinese Society of Gastroenterology,Chinese Medical Association updated the consensus on chronic gastritis in China(2017,Shanghai)and formulated the guidelines for diagnosis and treatment of chronic gastritis in China(2022,Shanghai)(herein after referred to as the"2022 guidelines for gastritis").Totally 53 recommendations were put forward on 9 clinical problems related to chronic gastritis in the 2022 guidelines for gastritis.This article interprets the 2022 guidelines for gastritis on gastric cancer risk stratification and endoscopic surveillance strategies for atrophic gastritis.

Chronic GastritisGastritis,AtrophicCarcinomatous ChangeRisk AssessmentMonitoringGuideline Interpretation

雒博晗、韩国宏

展开 >

西安国际医学中心医院消化内科(710100)

慢性胃炎 胃炎,萎缩性 癌变 危险性评估 监测 指南解读

2023

胃肠病学
上海交通大学医学院附属仁济医院

胃肠病学

CSTPCD
影响因子:1.217
ISSN:1008-7125
年,卷(期):2023.28(9)
  • 21